Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vancomycin dose titration guided by therapeutic drug monitoring
ChiCTR-ONC-13003564Phase 4Completed
- Sponsor
- ICU Department of Qilu Hospital of Shandong University
- Start
- Oct 2013
- Modality
- Antimicrobial Peptides → Native Peptides → Peptides, Cyclic Peptides → Modified Peptides → Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of vancomycin in Infection, sponsored by ICU Department of Qilu Hospital of Shandong University. Primary endpoint: Serum drug concentration. Started Oct 2013; status: completed.
02
Drugs
vancomycin
03
Conditions
Infection
Beyond the preview
Go deeper on ChiCTR-ONC-13003564.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-ONC-13003564.